A paradigm shift in the development of anti-cancer drugs is the goal of a BMBF-funded initiative that the NMI is working on with clinical researchers, biotech companies and bioinformaticians. Instead
Intelligent materials for the treatment of inflammation of the joints Intelligent materials for the treatment of inflammation of the joints The project aims to establish a material platform for the lo
AI-assisted diagnostics declare war on lung cancer Lung cancer is one of the most common cancers in Germany and at the same time has a particularly high mortality rate. One of the reasons for this is
The progress of biomedical research is spectacular, but its pace is threatened by important regulation. Feel free to read the press release from Meinungsbarometer. The progress of biomedical research
Interview with Prof. Dr. Peter Loskill - Group Leader Organ-on-Chip Peter Loskill is researching methods to replace animal testing. Alternatives are growing in his test tubes. Click here for the artic
Exchange about to ME / CFS - better understand disease mechanisms In Germany, ME/CFS is currently estimated to affect about 300,000 people, although the numbers may be 5-10 times higher due to misdiag
Exchange on common topics in the fields of biomedicine, material sciences and PharmaBiotech. Right at the beginning of the year, the institute received a distinguished visitor: the new rector of the U
Prof. Katja Schenke-Layland on site in Brussels with Minister President Kretschmann for an exchange on EU funding policy. Together with Minister President Winfried Kretschmann, Professor Katja Schenke
The Minister of Economics, Labor and Tourism, Dr. Hoffmeister-Kraut, presents the NMI and the Werner Siemens Imaging Center with the funding decision for the project Biologicals Development Center Reu
